Investment Instruments

October's race to zero commissions might have played into the decision.

Pharma companies say they need to charge high prices to support drug R&D--but do they really?

Will scandals lead to change?

Risk stands in the middle of one of investing's greatest mixed metaphors.

At some point you'll have an HSA question. Here are some FAQs hand-picked for usefulness, with a few tossed in because they're cool.

Proposed rule changes would let RIAs use testimonials and endorsements, but several actions would be prohibited.